Researchers with the University North Texas have examined optimized curcumin [Longvida] supplementation as a therapy for Exercise-Induced Muscle Damage (EIMD) and Delayed Onset Muscle Soreness (DOMS) impact post training and Activities of Daily Living (ADL). The study was intended to determine the effects of 400mg/day of Longvida Optimized Curcumin “on muscle and ADL soreness, creatine kinase (CK), and inflammatory cytokines (TNF-α, IL-6, IL-8, IL-10) following exercise-induced muscle damage.” 
 
Twenty-eight participants were randomly assigned to either 400mg/day supplementation of Longvida or placebo, and then participated in a leg press exercise. Blood samples were taken before the exercise, and at one, two, three, and four days post exercise. These were used to measure and analyze creatine kinase (CK) and inflammatory cytokines, which were analyzed by ANOVA with p<0.05. 
 
The study noted: “Curcumin supplementation resulted in significantly smaller increases in CK (-48%), TNF-α (-25%), and IL-8 (-21%) following EIMD compared to placebo. We observed no significant decreases in IL-6, IL-10, or quadriceps muscle soreness between conditions for this sample size.” Based on these results, a larger sample size should be examined to see if the trending lowering effect of these other markers could be significant. 
 
Additionally, the findings indicated that the consumption of Longvida Optimized Curcumin reduced inflammation, but not quadriceps muscle soreness during recovery post induction of exercise muscle soreness. Researchers suggested observed improvements in biological inflammation may translate to faster recovery and improved functional capacity during subsequent exercise sessions.
 
In summary, researchers’ findings “support the use of oral curcumin supplementation [as Longvida Optimized Curcumin] to reduce the symptoms of EIMD.” Sonya Cropper, vice president of marketing & innovation with Verdure Sciences, stated, “I am pleased to see additional support of Longvida’s efficacious capability to promote active lifestyle activities. It is impressive to see a second clinical that supports Longvida’s impact on particular biomarkers that influence health.” 
 
For more information: www.longvida.com